911 Stock Overview
An investment holding company, engages in the sale of health-care products and electronic component products in Hong Kong. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Qianhai Health Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.32 |
| 52 Week High | HK$0.72 |
| 52 Week Low | HK$0.14 |
| Beta | 0.094 |
| 11 Month Change | -7.35% |
| 3 Month Change | 30.17% |
| 1 Year Change | -12.50% |
| 33 Year Change | -56.25% |
| 5 Year Change | -85.35% |
| Change since IPO | -99.48% |
Recent News & Updates
Shareholder Returns
| 911 | HK Electronic | HK Market | |
|---|---|---|---|
| 7D | 0% | 1.7% | -1.5% |
| 1Y | -12.5% | 14.3% | 13.6% |
Return vs Industry: 911 underperformed the Hong Kong Electronic industry which returned 14.3% over the past year.
Return vs Market: 911 underperformed the Hong Kong Market which returned 13.6% over the past year.
Price Volatility
| 911 volatility | |
|---|---|
| 911 Average Weekly Movement | 25.1% |
| Electronic Industry Average Movement | 9.9% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 18.9% |
| 10% least volatile stocks in HK Market | 4.2% |
Stable Share Price: 911's share price has been volatile over the past 3 months compared to the Hong Kong market.
Volatility Over Time: 911's weekly volatility has increased from 16% to 25% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 16 | n/a | www.qianhaihealth.com.hk |
Qianhai Health Holdings Limited, an investment holding company, engages in the sale of health-care products and electronic component products in Hong Kong. The company operates through Health-Care Products and Electronic Component Products segments. It offers Chinese herbal medicines, American ginseng, and other healthy drinks products.
Qianhai Health Holdings Limited Fundamentals Summary
| 911 fundamental statistics | |
|---|---|
| Market cap | HK$53.38m |
| Earnings (TTM) | HK$74.96m |
| Revenue (TTM) | HK$928.36m |
0.7x
P/E Ratio0.1x
P/S RatioIs 911 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 911 income statement (TTM) | |
|---|---|
| Revenue | HK$928.36m |
| Cost of Revenue | HK$801.25m |
| Gross Profit | HK$127.12m |
| Other Expenses | HK$52.16m |
| Earnings | HK$74.96m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.44 |
| Gross Margin | 13.69% |
| Net Profit Margin | 8.07% |
| Debt/Equity Ratio | 0% |
How did 911 perform over the long term?
See historical performance and comparison